Pediatric anesthesia & critical care

Anesthetic Management for Aspiration Thrombectomy Using the Penumbra Indigo System in Pediatric Patients with Congenital Heart Disease

J Cardiothorac Vasc AnesthPublished Retrospective chart review

Authors' conclusion

Mechanical aspiration thrombectomy is being increasingly used to treat critically ill pediatric patients and presents unique anesthetic considerations, particularly related to the need for volume and blood product resuscitation.

Study context

Population
Patients aged <18 years with congenital heart disease undergoing aspiration thrombectomy, quaternary academic children's hospital, November 2017 to February 2022
Participants
13 patients
Outcome
Clinical characteristics and outcomes, including transfusion requirements
Methodological detailssingle-centre
  • Single-centre

Main finding

As reported in the abstract

Median age (years)
3.8
Median weight (kg)
15.2
Palliated single ventricle circulation
7
Biventricular circulation
6
Intensive care unit (ICU) admission before procedure
9
ICU admission after procedure
12
Indication: systemic venous thrombus
7
Indication: pulmonary arterial thrombus
3
Indication: systemic arterial thrombus
2
Indication: systemic-to-pulmonary shunt occlusion
1
Median estimated blood loss, mL/kg (IQR 1.4-15.8; range 0.5-51.5)
7.7
Intraoperative transfusion required (RBC n = 4, FFP n = 2, platelets n = 3, cryoprecipitate n = 1)
7
Median transfusion volume in transfused patients, mL/kg (IQR 14.1-59.7; 9.3-132.8)
22
Successful thrombectomy
8 of 13
Recurrent thrombosis among successful
3 of these 8

Observational data: associations, not effects.

Original publication

Anesthetic Management for Aspiration Thrombectomy Using the Penumbra Indigo System in Pediatric Patients with Congenital Heart Disease. J Cardiothorac Vasc Anesth. Published 10 August 2024. doi:10.1053/j.jvca.2024.08.005

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.